Clinical Trials · NCT01272232
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 846
- Start date
- Jun 2011
- Locations
- 161 sites, 13 countries
- Primary endpoint
- Change (%) From Baseline in Body Weight (Fasting)